Indication

Desmoid tumor

A desmoid tumor, also known as aggressive fibromatosis, is a rare, monoclonal fibroblastic proliferation arising from deep connective tissues such as fascia and musculoaponeurotic structures. Read more about Desmoid tumor

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Desmoid tumor therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Desmoid tumor preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Desmoid tumor.

A desmoid tumor, also known as aggressive fibromatosis, is a rare, monoclonal fibroblastic proliferation arising from deep connective tissues such as fascia and musculoaponeurotic structures.

It most commonly develops in young to middle-aged adults, appearing as abdominal wall, intra-abdominal, or extra-abdominal lesions in the limbs, chest wall, or head and neck.

Pathophysiologically, these neoplasms are driven by aberrant Wnt/beta-catenin signaling, typically stemming from somatic mutations in the *CTNNB1* gene or, less frequently, germline mutations in the *APC* gene associated with familial adenomatous polyposis.

Although desmoid tumors lack metastatic potential, they exhibit an unpredictable clinical course characterized by infiltrative local invasion into adjacent organs, nerves, and vessels, often resulting in significant pain, functional impairment, and high rates of local recurrence.

Personalize your experience

Follow Desmoid tumor and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it